NASDAQ:MDCX
Medicus Pharma Ltd.
Medicus Pharma Ltd. reported net income of −$47.3M in fiscal 2025. The diluted share count rose 79.7%.Summary generated from Medicus Pharma Ltd.'s SEC filings. Latest annual report filed Mar 25, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)n/a
Revenue growthn/a
Revenue, 5-yr CAGRn/a
Gross marginn/a
Operating marginn/a
Net marginn/a
ROICn/a
Return on equity−3083.1%
Debt / equityn/a
Free cash flown/a
FCF marginn/a
Share count change+79.7%
Financials
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | n/a | n/a | n/a |
| Operating income | −5 | −11 | −34 |
| Net income | −5 | −11 | −47 |
| Free cash flow | n/a | n/a | n/a |
Recent filings
- 8-KOther events
Oct 7, 2026 - 8-KTermination of a material agreement
Sep 14, 2026 - 8-KCurrent report
Sep 11, 2026 - 4Insider transaction report
Sep 8, 2026 - 4Insider transaction report
Sep 8, 2026 - 8-KEntry into a material agreement
Sep 3, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 12, 2026 - 8-KResults of a shareholder vote
Jun 4, 2026